Study Reveals Poor Prognostic Factors Associated With DLBCL of the Urinary Tract AJMC, 26 Aug 2021 Approximately 30% of non-Hodgkin lymphoma diagnoses are for DLBCL. The use of rituximab in combination with cyclophosphamide…